Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALB.L Regulatory News (ALB)

  • There is currently no data for ALB

Loan Agreement

6 Mar 2009 13:12

RNS Number : 4657O
Albany Capital PLC
06 March 2009
 



Albany Capital plc

Re: Loan Agreement

On 13 February 2009, Albany Capital plc ("Albany") announced that it had agreed to lend up to £1.75m on a secured short term basis at an interest rate of 18% and draw down fee of 3% to Hermes Financial Group (BVI) Ltd, ("Hermes"). Security is by way of charges in Albany's favour over approximately 5.6 million shares in Sorbic International plc ("Sorbic").

Further to the recent announcement, £1.5m of the loan has now been transferred which will repay a significant proportion of the outstanding debt owed by Hermes to Sorbic. The origins of this transaction arose when Honour Field ("HF"), now a wholly-owned subsidiary of Sorbic, received funds from Albany in July 2008. Prior to its acquisition in September 2008, and in breach of its agreement with Albany, HF transferred £2 million to Hermes. Accordingly, as Sorbic requires the funds to continue its capital project, Albany has made the transfer as the Board of Albany believe such a loan to be in the best interests of both Albany and Sorbic, a company in which Albany has a significant investment.

Enquiries:

John McLean, Chairman, Albany Capital

+44 (0)203 178 4506

James Joyce, WH Ireland

+44 (0) 207 220 1698

John Bick, Hansard Group

+44 (0) 7872 061007

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCCKAKDNBKDDNK
Date   Source Headline
12th Mar 20187:01 amRNSSignificant Customer Win
12th Mar 20187:00 amRNSFull Year Results
22nd Feb 20187:00 amRNSPilot Project with Leading Global Ad Agency
8th Feb 20182:34 pmRNSAlbert CEO Or Shani Wins 2018 BIG Innovation Award
23rd Jan 20182:00 pmRNSMao Keo joins Albert Technologies
9th Jan 20187:00 amRNS2017 Update and Capital Markets Dinner
22nd Dec 20177:00 amRNSExercise and Grant of Options
5th Dec 20174:40 pmRNSSecond Price Monitoring Extn
5th Dec 20174:35 pmRNSPrice Monitoring Extension
5th Dec 20177:00 amRNSSaaS Update & Cessation of Indirect Business
25th Sep 20177:00 amRNSAlbert Technologies Interim Results
27th Jul 20177:01 amRNSStrategic Partnership - Australia and New Zealand
27th Jul 20177:00 amRNSTrading update
12th Jul 201712:04 pmRNSCompany name change
26th Jun 20177:00 amRNSExercise of Options
22nd Jun 20172:17 pmRNSResult of AGM
15th May 20177:02 amRNSPDMR Shareholding
15th May 20177:01 amRNSNotice of AGM and Grant of Options
15th May 20177:00 amRNSPosting of Annual Report
10th Apr 20177:00 amRNSPDMR Shareholdings
7th Apr 201711:05 amRNSSecond Price Monitoring Extn
7th Apr 201711:00 amRNSPrice Monitoring Extension
3rd Apr 20177:01 amRNSDirector Appointment
3rd Apr 20177:00 amRNSFull Year Results
17th Mar 20177:00 amRNSSignificant Customer Win
14th Feb 20177:00 amRNSDirectorate Change
1st Feb 20177:00 amRNSTrading Update
18th Jan 20174:40 pmRNSSecond Price Monitoring Extn
18th Jan 20174:35 pmRNSPrice Monitoring Extension
26th Oct 20165:40 pmRNSExercise of Options
27th Sep 20167:00 amRNSDirector/PDMR Shareholdings
19th Sep 20167:00 amRNSInterim results
14th Sep 20162:05 pmRNSSecond Price Monitoring Extn
14th Sep 20162:00 pmRNSPrice Monitoring Extension
7th Jul 201611:10 amRNSResult of AGM
13th Jun 20162:30 pmRNSNotice of AGM and Grant of Options
27th Apr 201612:38 pmRNSPosting of Annual Report
14th Apr 20167:00 amRNSFinal Results for the year ended 31 December 2015
15th Feb 20167:00 amRNSHolding(s) in Company
10th Feb 20164:41 pmRNSSecond Price Monitoring Extn
10th Feb 20164:35 pmRNSPrice Monitoring Extension
31st Dec 20157:00 amRNSDirector Share Transfer
23rd Dec 20152:17 pmRNSDirector/PDMR Shareholding
17th Dec 20157:00 amRNSTrading and Business Review
9th Oct 20157:00 amRNSTrading Update
7th Sep 20152:05 pmRNSResult of EGM
13th Aug 20157:00 amRNSNotice of EGM
3rd Aug 20157:00 amRNSInterim Results
11th Jun 20157:00 amRNSFirst day of dealings on AIM
16th Jul 200911:00 amRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.